Novartis Doesn’t Exclude Cooperation With Roche: Le Temps
2014-11-28 18:47:52.938 GMT
By James Kraus
Nov. 28 (Bloomberg) -- Non-executive Chairman Joerg
Reinhardt plans modification of corporate culture at drugmaker,
Le Temps reports, citing interview.
* Co. to focus on opthamology, generics, cancer and heart
medications
* Informal discussions on different topics held routinely with
Roche, nothing specific at moment
* 33% stake in Roche remains a strategic, financial holding
* NOTE: Oct. 28, Novartis Profit Beats Estimates as New Drugs
Offset Diovan
For Related News and Information:
First Word scrolling panel: FIRST<GO>
First Word newswire: NH BFW<GO>
To contact the reporter on this story:
James Kraus in Geneva at +41-22-317-9232 or
jkraus2@bloomberg.net
To contact the editor responsible for this story:
Mariajose Vera at +49-89-244478-803 or
mvera1@bloomberg.net
2014-11-28 18:47:52.938 GMT
By James Kraus
Nov. 28 (Bloomberg) -- Non-executive Chairman Joerg
Reinhardt plans modification of corporate culture at drugmaker,
Le Temps reports, citing interview.
* Co. to focus on opthamology, generics, cancer and heart
medications
* Informal discussions on different topics held routinely with
Roche, nothing specific at moment
* 33% stake in Roche remains a strategic, financial holding
* NOTE: Oct. 28, Novartis Profit Beats Estimates as New Drugs
Offset Diovan
For Related News and Information:
First Word scrolling panel: FIRST<GO>
First Word newswire: NH BFW<GO>
To contact the reporter on this story:
James Kraus in Geneva at +41-22-317-9232 or
jkraus2@bloomberg.net
To contact the editor responsible for this story:
Mariajose Vera at +49-89-244478-803 or
mvera1@bloomberg.net